Skip to main content
Erschienen in: Inflammation 3/2013

01.06.2013

Interaction Between Oral Lichen Planus and Chronic Periodontitis with Th17-Associated Cytokines in Serum

verfasst von: Hui Wang, Zhenhua Luo, Lei Lei, Zheng Sun, Min Zhou, Hongxia Dan, Xin Zeng, Qianming Chen

Erschienen in: Inflammation | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to compare the expression levels of interleukin (IL)-17 IL-17 and IL-23 in serum from patients with both oral lichen planus and chronic periodontitis (OLP-CP), patients only with oral lichen planus (OLP), patients only with chronic periodontitis (CP), and healthy controls (HC). The serum samples were collected from 35 OLP-CP patients, 35 OLP patients, 30 CP patients, and 30 healthy controls. ELISA test was used to detect expression levels of IL-17 and IL-23 in serum from these four groups. ELISA analysis showed significantly elevated levels of serum IL-17 in OLP-CP group compared with OLP group (P < 0.05) and HC group (P < 0.01). Serum IL-23 result showed that there was an increased expression level in OLP-CP compared with HC group (P < 0.01). Additionally, female OLP-CP group showed elevated level of serum IL-17 compared with female OLP group, and also erosive OLP-CP group demonstrated increased serum IL-17 level compared with erosive OLP group. Moreover, analysis showed positive significant correlations of serum IL-17 level with probing depth (P < 0.05) and plaque index (P < 0.05) in erosive OLP-CP patients. This study indicates that OLP-CP patients get higher expression level of serum IL-17 and had susceptibility to erosive or female subtype, which indicated that IL-17 may participate in the disease immunopathogenesis of both common oral diseases.
Literatur
1.
Zurück zum Zitat Preshaw, P.M., A.L. Alba, D. Herrera, et al. 2012. Periodontitis and diabetes: A two-way relationship. Diabetologia 55(1): 21–31.PubMedCrossRef Preshaw, P.M., A.L. Alba, D. Herrera, et al. 2012. Periodontitis and diabetes: A two-way relationship. Diabetologia 55(1): 21–31.PubMedCrossRef
2.
Zurück zum Zitat Potikuri, D., K.C. Dannana, S. Kanchinadam, et al. 2012. Periodontal disease is significantly higher in non-smoking treatment-naive rheumatoid arthritis patients: Results from a case–control study. Annals of the Rheumatic Diseases 71(9): 1541–1544.PubMed Potikuri, D., K.C. Dannana, S. Kanchinadam, et al. 2012. Periodontal disease is significantly higher in non-smoking treatment-naive rheumatoid arthritis patients: Results from a case–control study. Annals of the Rheumatic Diseases 71(9): 1541–1544.PubMed
3.
Zurück zum Zitat Detert, J., N. Pischon, G.R. Burmester, and F. Buttgereit. 2010. The association between rheumatoid arthritis and periodontal disease. Arthritis Research & Therapy 12(5): 218.CrossRef Detert, J., N. Pischon, G.R. Burmester, and F. Buttgereit. 2010. The association between rheumatoid arthritis and periodontal disease. Arthritis Research & Therapy 12(5): 218.CrossRef
4.
Zurück zum Zitat Engebretson, S., R. Chertog, A. Nichols, J. Hey-Hadavi, R. Celenti, and J. Grbic. 2007. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. Journal of Clinical Periodontology 34(1): 18–24.PubMedCrossRef Engebretson, S., R. Chertog, A. Nichols, J. Hey-Hadavi, R. Celenti, and J. Grbic. 2007. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. Journal of Clinical Periodontology 34(1): 18–24.PubMedCrossRef
5.
Zurück zum Zitat Kobayashi, T., A. Murasawa, Y. Komatsu, et al. 2010. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. Journal of Periodontology 81(5): 650–657.PubMedCrossRef Kobayashi, T., A. Murasawa, Y. Komatsu, et al. 2010. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. Journal of Periodontology 81(5): 650–657.PubMedCrossRef
6.
Zurück zum Zitat Queiroz-Junior, C.M., M.F. Madeira, F.M. Coelho, et al. 2011. Experimental arthritis triggers periodontal disease in mice: Involvement of TNF-alpha and the oral microbiota. Journal of Immunology 187(7): 3821–3830.CrossRef Queiroz-Junior, C.M., M.F. Madeira, F.M. Coelho, et al. 2011. Experimental arthritis triggers periodontal disease in mice: Involvement of TNF-alpha and the oral microbiota. Journal of Immunology 187(7): 3821–3830.CrossRef
7.
Zurück zum Zitat Silverman Jr., S., M. Gorsky, and F. Lozada-Nur. 1985. A prospective follow-up study of 570 patients with oral lichen planus: Persistence, remission, and malignant association. Oral Surgery, Oral Medicine, and Oral Pathology 60(1): 30–34.PubMedCrossRef Silverman Jr., S., M. Gorsky, and F. Lozada-Nur. 1985. A prospective follow-up study of 570 patients with oral lichen planus: Persistence, remission, and malignant association. Oral Surgery, Oral Medicine, and Oral Pathology 60(1): 30–34.PubMedCrossRef
8.
Zurück zum Zitat Mignogna, M.D., M.L. Lo, R.L. Lo, S. Fedele, E. Ruoppo, and E. Bucci. 2001. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: A 5-year experience. Oral Oncology 37(3): 262–267.PubMedCrossRef Mignogna, M.D., M.L. Lo, R.L. Lo, S. Fedele, E. Ruoppo, and E. Bucci. 2001. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: A 5-year experience. Oral Oncology 37(3): 262–267.PubMedCrossRef
9.
Zurück zum Zitat Van der Meij, E.H., P.D. Bezemer, and I. van der Waal. 2002. Cost-effectiveness of screening for the possible development of cancer in patients with oral lichen planus. Community Dentistry and Oral Epidemiology 30(5): 342–51.PubMedCrossRef Van der Meij, E.H., P.D. Bezemer, and I. van der Waal. 2002. Cost-effectiveness of screening for the possible development of cancer in patients with oral lichen planus. Community Dentistry and Oral Epidemiology 30(5): 342–51.PubMedCrossRef
10.
Zurück zum Zitat Lopez-Jornet, P., and F. Camacho-Alonso. 2012. Periodontal conditions in patients with oral lichen planus: A pilot study. Quintessence International 43(2): 147–152.PubMed Lopez-Jornet, P., and F. Camacho-Alonso. 2012. Periodontal conditions in patients with oral lichen planus: A pilot study. Quintessence International 43(2): 147–152.PubMed
11.
Zurück zum Zitat Azizi, A., and M. Rezaee. 2012. Comparison of periodontal status in gingival oral lichen planus patients and healthy subjects. Dermatol Res Pract. 2012: 561232.PubMed Azizi, A., and M. Rezaee. 2012. Comparison of periodontal status in gingival oral lichen planus patients and healthy subjects. Dermatol Res Pract. 2012: 561232.PubMed
12.
Zurück zum Zitat Ramon-Fluixa, C., J. Bagan-Sebastian, M. Milian-Masanet, and C. Scully. 1999. Periodontal status in patients with oral lichen planus: A study of 90 cases. Oral Diseases 5(4): 303–306.PubMedCrossRef Ramon-Fluixa, C., J. Bagan-Sebastian, M. Milian-Masanet, and C. Scully. 1999. Periodontal status in patients with oral lichen planus: A study of 90 cases. Oral Diseases 5(4): 303–306.PubMedCrossRef
13.
Zurück zum Zitat Mignogna, M.D., R.L. Lo, and S. Fedele. 2005. Gingival involvement of oral lichen planus in a series of 700 patients. Journal of Clinical Periodontology 32(10): 1029–1033.PubMedCrossRef Mignogna, M.D., R.L. Lo, and S. Fedele. 2005. Gingival involvement of oral lichen planus in a series of 700 patients. Journal of Clinical Periodontology 32(10): 1029–1033.PubMedCrossRef
14.
Zurück zum Zitat Romagnani, S., E. Maggi, F. Liotta, L. Cosmi, and F. Annunziato. 2009. Properties and origin of human Th17 cells. Molecular Immunology 47(1): 3–7.PubMedCrossRef Romagnani, S., E. Maggi, F. Liotta, L. Cosmi, and F. Annunziato. 2009. Properties and origin of human Th17 cells. Molecular Immunology 47(1): 3–7.PubMedCrossRef
15.
Zurück zum Zitat Tesmer, L.A., S.K. Lundy, S. Sarkar, and D.A. Fox. 2008. Th17 cells in human disease. Immunology Reviews 223: 87–113.CrossRef Tesmer, L.A., S.K. Lundy, S. Sarkar, and D.A. Fox. 2008. Th17 cells in human disease. Immunology Reviews 223: 87–113.CrossRef
16.
Zurück zum Zitat Beklen, A., M. Ainola, M. Hukkanen, C. Gurgan, T. Sorsa, and Y.T. Konttinen. 2007. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. Journal of Dental Research 86(4): 347–351.PubMedCrossRef Beklen, A., M. Ainola, M. Hukkanen, C. Gurgan, T. Sorsa, and Y.T. Konttinen. 2007. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. Journal of Dental Research 86(4): 347–351.PubMedCrossRef
17.
Zurück zum Zitat Yu, J.J., M.J. Ruddy, G.C. Wong, et al. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: Recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109(9): 3794–3802.PubMedCrossRef Yu, J.J., M.J. Ruddy, G.C. Wong, et al. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: Recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109(9): 3794–3802.PubMedCrossRef
18.
Zurück zum Zitat Gaffen, S.L., and G. Hajishengallis. 2008. A new inflammatory cytokine on the block: Re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. Journal of Dental Research 87(9): 817–828.PubMedCrossRef Gaffen, S.L., and G. Hajishengallis. 2008. A new inflammatory cytokine on the block: Re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. Journal of Dental Research 87(9): 817–828.PubMedCrossRef
19.
Zurück zum Zitat Oppmann, B., R. Lesley, B. Blom, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13(5): 715–725.PubMedCrossRef Oppmann, B., R. Lesley, B. Blom, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13(5): 715–725.PubMedCrossRef
20.
Zurück zum Zitat McGeachy, M.J., and D.J. Cua. 2008. Th17 cell differentiation: The long and winding road. Immunity 28(4): 445–453.PubMedCrossRef McGeachy, M.J., and D.J. Cua. 2008. Th17 cell differentiation: The long and winding road. Immunity 28(4): 445–453.PubMedCrossRef
21.
Zurück zum Zitat Kreymborg, K., R. Etzensperger, L. Dumoutier, et al. 2007. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. Journal of Immunology 179(12): 8098–8104. Kreymborg, K., R. Etzensperger, L. Dumoutier, et al. 2007. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. Journal of Immunology 179(12): 8098–8104.
22.
Zurück zum Zitat Tan, Z.Y., K.W. Bealgey, Y. Fang, Y.M. Gong, and S. Bao. 2009. Interleukin-23: Immunological roles and clinical implications. The International Journal of Biochemistry & Cell Biology 41(4): 733–735.CrossRef Tan, Z.Y., K.W. Bealgey, Y. Fang, Y.M. Gong, and S. Bao. 2009. Interleukin-23: Immunological roles and clinical implications. The International Journal of Biochemistry & Cell Biology 41(4): 733–735.CrossRef
23.
Zurück zum Zitat Ohyama, H., N. Kato-Kogoe, A. Kuhara, et al. 2009. The involvement of IL-23 and the Th17 pathway in periodontitis. Journal of Dental Research 88(7): 633–638.PubMedCrossRef Ohyama, H., N. Kato-Kogoe, A. Kuhara, et al. 2009. The involvement of IL-23 and the Th17 pathway in periodontitis. Journal of Dental Research 88(7): 633–638.PubMedCrossRef
24.
Zurück zum Zitat Vered M, Furth E, Shalev Y, Dayan D. 2012. Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters. Clin Oral Investig. Vered M, Furth E, Shalev Y, Dayan D. 2012. Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters. Clin Oral Investig.
25.
Zurück zum Zitat Bai, J., L. Jiang, M. Lin, X. Zeng, Z. Wang, and Q. Chen. 2009. Association of polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes with oral lichen planus: A study in a Chinese cohort with Han ethnicity. Journal of Interferon & Cytokine Research 29(7): 381–388.CrossRef Bai, J., L. Jiang, M. Lin, X. Zeng, Z. Wang, and Q. Chen. 2009. Association of polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes with oral lichen planus: A study in a Chinese cohort with Han ethnicity. Journal of Interferon & Cytokine Research 29(7): 381–388.CrossRef
26.
Zurück zum Zitat Dan, H., W. Liu, J. Wang, et al. 2011. Elevated IL-10 concentrations in serum and saliva from patients with oral lichen planus. Quintessence International 42(2): 157–163.PubMed Dan, H., W. Liu, J. Wang, et al. 2011. Elevated IL-10 concentrations in serum and saliva from patients with oral lichen planus. Quintessence International 42(2): 157–163.PubMed
27.
Zurück zum Zitat Zhang, Y., M. Lin, S. Zhang, et al. 2008. NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: A study in an ethnic Chinese population. Cytokine 41(2): 144–149.PubMedCrossRef Zhang, Y., M. Lin, S. Zhang, et al. 2008. NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: A study in an ethnic Chinese population. Cytokine 41(2): 144–149.PubMedCrossRef
28.
Zurück zum Zitat Dan, H., W. Liu, Y. Zhou, J. Wang, Q. Chen, and X. Zeng. 2010. Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population. Inflammation 33(2): 76–81.PubMedCrossRef Dan, H., W. Liu, Y. Zhou, J. Wang, Q. Chen, and X. Zeng. 2010. Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population. Inflammation 33(2): 76–81.PubMedCrossRef
29.
Zurück zum Zitat Bai, J., Y. Zhang, M. Lin, et al. 2007. Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: A study in an ethnic Chinese cohort. Tissue Antigens 70(5): 390–397.PubMedCrossRef Bai, J., Y. Zhang, M. Lin, et al. 2007. Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: A study in an ethnic Chinese cohort. Tissue Antigens 70(5): 390–397.PubMedCrossRef
30.
Zurück zum Zitat Kalogerakou, F., E. Albanidou-Farmaki, A.K. Markopoulos, and D.Z. Antoniades. 2008. Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. Hippokratia. 12(4): 230–235.PubMed Kalogerakou, F., E. Albanidou-Farmaki, A.K. Markopoulos, and D.Z. Antoniades. 2008. Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. Hippokratia. 12(4): 230–235.PubMed
31.
Zurück zum Zitat Rhodus, N.L., B. Cheng, W. Bowles, S. Myers, L. Miller, and F. Ondrey. 2006. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Oral Diseases 12(2): 112–116.PubMedCrossRef Rhodus, N.L., B. Cheng, W. Bowles, S. Myers, L. Miller, and F. Ondrey. 2006. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Oral Diseases 12(2): 112–116.PubMedCrossRef
32.
Zurück zum Zitat Roopashree, M.R., R.V. Gondhalekar, M.C. Shashikanth, J. George, S.H. Thippeswamy, and A. Shukla. 2010. Pathogenesis of oral lichen planus—A review. Journal of Oral Pathology & Medicine 39(10): 729–734.CrossRef Roopashree, M.R., R.V. Gondhalekar, M.C. Shashikanth, J. George, S.H. Thippeswamy, and A. Shukla. 2010. Pathogenesis of oral lichen planus—A review. Journal of Oral Pathology & Medicine 39(10): 729–734.CrossRef
33.
Zurück zum Zitat Pekiner, F.N., G.Y. Demirel, M.O. Borahan, and S. Ozbayrak. 2012. Cytokine profiles in serum of patients with oral lichen planus. Cytokine 60(3): 701–706.PubMedCrossRef Pekiner, F.N., G.Y. Demirel, M.O. Borahan, and S. Ozbayrak. 2012. Cytokine profiles in serum of patients with oral lichen planus. Cytokine 60(3): 701–706.PubMedCrossRef
34.
Zurück zum Zitat Mucida, D., and S. Salek-Ardakani. 2009. Regulation of TH17 cells in the mucosal surfaces. The Journal of Allergy and Clinical Immunology 123(5): 997–1003.PubMedCrossRef Mucida, D., and S. Salek-Ardakani. 2009. Regulation of TH17 cells in the mucosal surfaces. The Journal of Allergy and Clinical Immunology 123(5): 997–1003.PubMedCrossRef
35.
Zurück zum Zitat Karagouni, E.E., E.N. Dotsika, and A. Sklavounou. 1994. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. Journal of Oral Pathology & Medicine 23(1): 28–35.CrossRef Karagouni, E.E., E.N. Dotsika, and A. Sklavounou. 1994. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. Journal of Oral Pathology & Medicine 23(1): 28–35.CrossRef
36.
Zurück zum Zitat Simark-Mattsson, C., G. Bergenholtz, M. Jontell, et al. 1999. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Archives of Oral Biology 44(6): 499–507.PubMedCrossRef Simark-Mattsson, C., G. Bergenholtz, M. Jontell, et al. 1999. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Archives of Oral Biology 44(6): 499–507.PubMedCrossRef
37.
Zurück zum Zitat Appay, V., R.A. van Lier, F. Sallusto, and M. Roederer. 2008. Phenotype and function of human T lymphocyte subsets: Consensus and issues. Cytometry Part A 73(11): 975–83.CrossRef Appay, V., R.A. van Lier, F. Sallusto, and M. Roederer. 2008. Phenotype and function of human T lymphocyte subsets: Consensus and issues. Cytometry Part A 73(11): 975–83.CrossRef
38.
Zurück zum Zitat Sallusto, F., and A. Lanzavecchia. 2009. Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity. European Journal of Immunology 39(8): 2076–2082.PubMedCrossRef Sallusto, F., and A. Lanzavecchia. 2009. Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity. European Journal of Immunology 39(8): 2076–2082.PubMedCrossRef
39.
Zurück zum Zitat Pezelj-Ribaric, S., I.B. Prso, M. Abram, I. Glazar, G. Brumini, and M. Simunovic-Soskic. 2004. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediators of Inflammation 13(2): 131–133.PubMedCrossRef Pezelj-Ribaric, S., I.B. Prso, M. Abram, I. Glazar, G. Brumini, and M. Simunovic-Soskic. 2004. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediators of Inflammation 13(2): 131–133.PubMedCrossRef
40.
Zurück zum Zitat Mazzarella, N., F. Femiano, F. Gombos, A. De Rosa, and M. Giuliano. 2006. Matrix metalloproteinase gene expression in oral lichen planus: Erosive vs. reticular forms. Journal of the European Academy of Dermatology and Venereology 20(8): 953–957.PubMed Mazzarella, N., F. Femiano, F. Gombos, A. De Rosa, and M. Giuliano. 2006. Matrix metalloproteinase gene expression in oral lichen planus: Erosive vs. reticular forms. Journal of the European Academy of Dermatology and Venereology 20(8): 953–957.PubMed
41.
Zurück zum Zitat Tao, X., Y. Huang, R. Li, et al. 2007. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 103(5): 661–669.PubMedCrossRef Tao, X., Y. Huang, R. Li, et al. 2007. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 103(5): 661–669.PubMedCrossRef
42.
Zurück zum Zitat Liu, W., H. Dan, Z. Wang, et al. 2009. IFN-gamma and IL-4 in saliva of patients with oral lichen planus: A study in an ethnic Chinese population. Inflammation 32(3): 176–181.PubMedCrossRef Liu, W., H. Dan, Z. Wang, et al. 2009. IFN-gamma and IL-4 in saliva of patients with oral lichen planus: A study in an ethnic Chinese population. Inflammation 32(3): 176–181.PubMedCrossRef
43.
Zurück zum Zitat Asadullah, K., W. Sterry, and H.D. Volk. 2003. Interleukin-10 therapy—Review of a new approach. Pharmacological Reviews 55(2): 241–269.PubMedCrossRef Asadullah, K., W. Sterry, and H.D. Volk. 2003. Interleukin-10 therapy—Review of a new approach. Pharmacological Reviews 55(2): 241–269.PubMedCrossRef
44.
Zurück zum Zitat Groux, H., and F. Cottrez. 2003. The complex role of interleukin-10 in autoimmunity. Journal of Autoimmunity 20(4): 281–285.PubMedCrossRef Groux, H., and F. Cottrez. 2003. The complex role of interleukin-10 in autoimmunity. Journal of Autoimmunity 20(4): 281–285.PubMedCrossRef
45.
Zurück zum Zitat Rhodus, N.L., B. Cheng, and F. Ondrey. 2007. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators of Inflammation 2007: 19854.PubMedCrossRef Rhodus, N.L., B. Cheng, and F. Ondrey. 2007. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators of Inflammation 2007: 19854.PubMedCrossRef
46.
Zurück zum Zitat Xue, J.L., M.W. Fan, S.Z. Wang, X.M. Chen, Y. Li, and L. Wang. 2005. A clinical study of 674 patients with oral lichen planus in China. Journal of Oral Pathology & Medicine 34(8): 467–472.CrossRef Xue, J.L., M.W. Fan, S.Z. Wang, X.M. Chen, Y. Li, and L. Wang. 2005. A clinical study of 674 patients with oral lichen planus in China. Journal of Oral Pathology & Medicine 34(8): 467–472.CrossRef
47.
Zurück zum Zitat Peng, S.L. 2006. The T-box transcription factor T-bet in immunity and autoimmunity. Cellular and molecular immunology 3(2): 87–95.PubMed Peng, S.L. 2006. The T-box transcription factor T-bet in immunity and autoimmunity. Cellular and molecular immunology 3(2): 87–95.PubMed
48.
Zurück zum Zitat Hasler, P., and M. Zouali. 2005. Immune receptor signaling, aging, and autoimmunity. Cellular Immunology 233(2): 102–108.PubMedCrossRef Hasler, P., and M. Zouali. 2005. Immune receptor signaling, aging, and autoimmunity. Cellular Immunology 233(2): 102–108.PubMedCrossRef
49.
Zurück zum Zitat Honda, T., H. Domon, T. Okui, K. Kajita, R. Amanuma, and K. Yamazaki. 2006. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clinical and Experimental Immunology 144(1): 35–40.PubMedCrossRef Honda, T., H. Domon, T. Okui, K. Kajita, R. Amanuma, and K. Yamazaki. 2006. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clinical and Experimental Immunology 144(1): 35–40.PubMedCrossRef
50.
Zurück zum Zitat Gemmell, E., K. Yamazaki, and G.J. Seymour. 2002. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Critical Reviews in Oral Biology and Medicine 13(1): 17–34.PubMedCrossRef Gemmell, E., K. Yamazaki, and G.J. Seymour. 2002. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Critical Reviews in Oral Biology and Medicine 13(1): 17–34.PubMedCrossRef
51.
Zurück zum Zitat Yago, T., Y. Nanke, N. Ichikawa, et al. 2009. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: A novel mechanism of osteoclastogenesis by IL-17. Journal of Cellular Biochemistry 108(4): 947–955.PubMedCrossRef Yago, T., Y. Nanke, N. Ichikawa, et al. 2009. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: A novel mechanism of osteoclastogenesis by IL-17. Journal of Cellular Biochemistry 108(4): 947–955.PubMedCrossRef
52.
Zurück zum Zitat Dong, C. 2008. TH17 cells in development: An updated view of their molecular identity and genetic programming. Nature Reviews Immunology 8(5): 337–348.PubMedCrossRef Dong, C. 2008. TH17 cells in development: An updated view of their molecular identity and genetic programming. Nature Reviews Immunology 8(5): 337–348.PubMedCrossRef
53.
Zurück zum Zitat Sato, K., A. Suematsu, K. Okamoto, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. The Journal of Experimental Medicine 203(12): 2673–2682.PubMedCrossRef Sato, K., A. Suematsu, K. Okamoto, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. The Journal of Experimental Medicine 203(12): 2673–2682.PubMedCrossRef
54.
Zurück zum Zitat Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000. 2004. 35: 21–41. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000. 2004. 35: 21–41.
55.
Zurück zum Zitat Pestka, S., C.D. Krause, D. Sarkar, M.R. Walter, Y. Shi, and P.B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annual Review of Immunology 22: 929–979.PubMedCrossRef Pestka, S., C.D. Krause, D. Sarkar, M.R. Walter, Y. Shi, and P.B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annual Review of Immunology 22: 929–979.PubMedCrossRef
56.
Zurück zum Zitat Garlet, G.P., C.R. Cardoso, A.P. Campanelli, W. Martins Jr., and J.S. Silva. 2006. Expression of suppressors of cytokine signaling in diseased periodontal tissues: A stop signal for disease progression. Journal of Periodontal Research 41(6): 580–584.PubMedCrossRef Garlet, G.P., C.R. Cardoso, A.P. Campanelli, W. Martins Jr., and J.S. Silva. 2006. Expression of suppressors of cytokine signaling in diseased periodontal tissues: A stop signal for disease progression. Journal of Periodontal Research 41(6): 580–584.PubMedCrossRef
57.
Zurück zum Zitat Sasaki, H., Y. Okamatsu, T. Kawai, R. Kent, M. Taubman, and P. Stashenko. 2004. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. Journal of Periodontal Research 39(6): 432–441.PubMedCrossRef Sasaki, H., Y. Okamatsu, T. Kawai, R. Kent, M. Taubman, and P. Stashenko. 2004. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. Journal of Periodontal Research 39(6): 432–441.PubMedCrossRef
58.
Zurück zum Zitat Naundorf, S., M. Schroder, C. Hoflich, N. Suman, H.D. Volk, and G. Grutz. 2009. IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells. European Journal of Immunology 39(4): 1066–1077.PubMedCrossRef Naundorf, S., M. Schroder, C. Hoflich, N. Suman, H.D. Volk, and G. Grutz. 2009. IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells. European Journal of Immunology 39(4): 1066–1077.PubMedCrossRef
59.
Zurück zum Zitat Trombone, A.P., M. Claudino, P. Colavite, et al. 2010. Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences. Genes and Immunity 11(6): 479–489.PubMedCrossRef Trombone, A.P., M. Claudino, P. Colavite, et al. 2010. Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences. Genes and Immunity 11(6): 479–489.PubMedCrossRef
60.
Zurück zum Zitat Lester, S.R., J.L. Bain, R.B. Johnson, and F.G. Serio. 2007. Gingival concentrations of interleukin-23 and −17 at healthy sites and at sites of clinical attachment loss. Journal of Periodontology 78(8): 1545–1550.PubMedCrossRef Lester, S.R., J.L. Bain, R.B. Johnson, and F.G. Serio. 2007. Gingival concentrations of interleukin-23 and −17 at healthy sites and at sites of clinical attachment loss. Journal of Periodontology 78(8): 1545–1550.PubMedCrossRef
Metadaten
Titel
Interaction Between Oral Lichen Planus and Chronic Periodontitis with Th17-Associated Cytokines in Serum
verfasst von
Hui Wang
Zhenhua Luo
Lei Lei
Zheng Sun
Min Zhou
Hongxia Dan
Xin Zeng
Qianming Chen
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9594-2

Weitere Artikel der Ausgabe 3/2013

Inflammation 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.